China Health Group Inc. (HKG:8225)
Hong Kong · Delayed Price · Currency is HKD 0.0800
0.00 (0.00%)
Sep 18, 2026, 4:08 PM HKT
China Health Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 29.9 | 28.56 | 26.45 | 21.43 | 13.09 | 83.6 |
| 29.9 | 28.56 | 26.45 | 21.43 | 13.09 | 83.6 | |
Revenue Growth | 0.39% | 7.98% | 23.47% | 63.68% | -84.34% | 0.65% |
Cost of Revenue | 12.64 | 12.17 | 16.39 | 13.21 | 7.35 | 13.24 |
Gross Profit | 17.26 | 16.39 | 10.07 | 8.21 | 5.74 | 70.36 |
Selling, General & Admin | 5.02 | 5.1 | 10.08 | 7.61 | 13.97 | 21.39 |
Other Operating Expenses | -0 | - | - | - | -0.05 | -0 |
Operating Expenses | 31.46 | 31.54 | 24.88 | 65.54 | 21.75 | 28.27 |
Operating Income | -14.2 | -15.14 | -14.82 | -57.33 | -16.01 | 42.09 |
Interest Expense | -0 | - | - | - | -0.02 | -0.02 |
Interest & Investment Income | 0.07 | 0.07 | 0.06 | 0.12 | 0.2 | 0.43 |
Other Non Operating Income (Expenses) | 0.11 | 0.11 | 0.28 | -1 | - | - |
EBT Excluding Unusual Items | -14.02 | -14.96 | -14.47 | -58.21 | -15.83 | 42.5 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.02 |
Pretax Income | -14.02 | -14.96 | -14.47 | -58.21 | -15.83 | 42.52 |
Income Tax Expense | 0.14 | - | 0.05 | - | - | 6.2 |
Earnings From Continuing Operations | -14.17 | -14.96 | -14.52 | -58.21 | -15.83 | 36.33 |
Minority Interest in Earnings | - | - | - | 0.2 | - | - |
Net Income | -14.17 | -14.96 | -14.52 | -58.01 | -15.83 | 36.33 |
Net Income to Common | -14.17 | -14.96 | -14.52 | -58.01 | -15.83 | 36.33 |
Net Income Growth | - | - | - | - | - | -40.11% |
Shares Outstanding (Basic) | 995 | 995 | 995 | 995 | 995 | 995 |
Shares Outstanding (Diluted) | 995 | 995 | 995 | 995 | 995 | 995 |
Shares Change | - | - | - | - | - | -0.18% |
EPS (Basic) | -0.01 | -0.02 | -0.01 | -0.06 | -0.02 | 0.04 |
EPS (Diluted) | -0.01 | -0.02 | -0.01 | -0.06 | -0.02 | 0.04 |
EPS Growth | - | - | - | - | - | -39.98% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 10.08 | 7.58 | 8.52 | -4.88 | -5.16 | -10.28 |
Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | -0.01 | -0.01 | -0.01 |
Gross Margin | 57.73% | 57.39% | 38.05% | 38.33% | 43.87% | 84.16% |
Operating Margin | -47.50% | -53.02% | -56.01% | -267.59% | -122.31% | 50.34% |
Profit Margin | -47.38% | -52.38% | -54.88% | -270.78% | -120.90% | 43.45% |
Free Cash Flow Margin | 33.70% | 26.53% | 32.22% | -22.79% | -39.39% | -12.29% |
EBITDA | -13.41 | -14.41 | -14.21 | -57.1 | -15.86 | 42.29 |
EBITDA Margin | -44.85% | -50.46% | -53.72% | -266.50% | -121.16% | 50.58% |
D&A For EBITDA | 0.79 | 0.73 | 0.61 | 0.23 | 0.15 | 0.2 |
EBIT | -14.2 | -15.14 | -14.82 | -57.33 | -16.01 | 42.09 |
EBIT Margin | -47.50% | -53.02% | -56.01% | -267.59% | -122.31% | 50.34% |
Effective Tax Rate | - | - | - | - | - | 14.57% |